Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration

R Prince DavisBascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, FL, USA

Amy C ScheflerBascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, FL, USA

Timothy G MurrayBascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence[email protected]

Pages 703-707 | Published online: 28 Jun 2010

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

RosenfeldPJBrownDMHeierJSBoyerDSKaiserPKChungCYKimRYMARINA Study GroupRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
PubMed Web of Science ®Google Scholar
PriglingerSGWolfAHKreutzerTCKookDHoferAStraussRWAlgeCSKunzeCHaritoglouCKampikAIntravitreal vebacizumab injections for treatment of central retinal vein occlusion: six month results of a prospective trialRetina20072781004101218040236
PubMed Web of Science ®Google Scholar
ArevaloJFFromow-GuerraJQuiroz-MercadoHPrimary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-upOphthalmology2007114474375017398322
PubMed Web of Science ®Google Scholar
WuLMartinez-CastellanosMAQuiroz-MercadoHfor the Pan American Collaborative Retina Group (PACORES)Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Retina Study Group (PACORES)Graefes Arch Clin Exp Ophthalmol20082461818717674014
PubMed Web of Science ®Google Scholar
RosenfeldPJRichRMLalwaniGARanibizumab. Phase III clinical trial resultsOphthalmol Clin North Am200619336137216935211
PubMedGoogle Scholar
ChangLKSarrafDTears of the retinal pigment epithelium: an old problem in a new eraRetina200727552353417558312
PubMed Web of Science ®Google Scholar
RonanSMYoganathanPChienFYRetinal pigment epithelium tears after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degenerationRetina200727553554017558313
PubMed Web of Science ®Google Scholar
BrownDMKaiserPKMichelsMRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med2006355141432144417021319
PubMed Web of Science ®Google Scholar
GaudreaultJFeiDRusitJSubocPShiuVPreclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administrationInvest Ophthalmol Vis Sci200546272673315671306
PubMed Web of Science ®Google Scholar
NoroseKTaninoTSegawaKBilateral tears of the retinal pigment epitheliumBr J Ophthalmol19887286216273415959
PubMed Web of Science ®Google Scholar
KookDWolfANeubauerASRetinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD: frequency and progress [German]Ophthalmologe2008105215816417653552
PubMed Web of Science ®Google Scholar
OzkirişAErkiliçKComplications of intravitreal injection of triamcinolone acetonideCan J Ophthalmol2005401636815825532
PubMed Web of Science ®Google Scholar
SpaideRFLaudKFineHFIntravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degenerationRetina200626438339016603955
PubMed Web of Science ®Google Scholar
KissCMichelsSPragerFWeigertGGeitzenauerWSchmidt-ErfurthUEvaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumabRetina200626887788117031286
PubMed Web of Science ®Google Scholar
MarticorenaJGomez-UllaFRomanoMRLunaIRepeated psuedoendophthalmitis after combined photodynamic therapy and intravitreal triamcinoloneGraefes Arch Clin Exp Ophthalmol200724591403140417492302
PubMed Web of Science ®Google Scholar
ChiehJJFekratSLarge subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degenerationAnn Ophthalmol (Skokie)2007391515217914205
PubMedGoogle Scholar
ClearyCAJungkimSRavikumarKKelliherCAchesonRWHickey-DwyerMIntravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month resultsEye2008221828617891059
PubMed Web of Science ®Google Scholar
KambaTMcDonaldDMMechanisms of adverse effects of anti-VEGF therapy for cancerBr J Cancer200796121788179517519900
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date